4,442 results match your criteria: "Centre Hospitalier Lyon Sud.[Affiliation]"
Ann Surg Oncol
December 2024
Department of Surgical Oncology, Centre Hospitalier Lyon-sud, Lyon, France.
Injury
November 2024
Population Health Research Institute, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Background: Hip fractures carry a substantial risk of complications and death. This study aimed to report the 90-day incidence of mortality, major perioperative complications and in-hospital timelines after a hip fracture in the Spanish HIP ATTACK-1 trial cohort, comparing with the non-Spanish cohort.
Methods: Prospective cohort study of Spanish patients nested in the HIP ATTACK-1 trial.
J Crit Care
December 2024
Hospices Civils de Lyon, Immunology Laboratory, Hôpital E. Herriot, Lyon, France; Université de Lyon, EA 7426 "Pathophysiology of Injury-Induced Immunosuppression", Université Claude Bernard Lyon_1, Lyon, France. Electronic address:
J Neurol
October 2024
French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.
Ataxia with anti-regulator of G-protein signaling 8 autoantibodies (RGS8-Abs) is an autoimmune disease recently described in four patients. The present study aimed to identify other patients with RGS8-Abs, describe their clinical features, including the link between RGS8-related autoimmune cerebellar ataxia (ACA) and cancer. Patients with RGS8-Abs were identified retrospectively in the biological collections of the French Reference Center for Paraneoplastic Neurological Syndrome and the University of California San Francisco Center for Encephalitis and Meningitis.
View Article and Find Full Text PDFCancers (Basel)
August 2024
Faculté de Médecine Lyon-Est, Université Claude Bernard Lyon I, 69100 Villeurbanne, France.
This pilot study aimed to investigate the interest of high angular resolution diffusion imaging (HARDI) and tractography of the spinal cord (SC) in the management of patients with intramedullary tumors by providing predictive elements for tumor resection. Eight patients were included in a prospective study. HARDI images of the SC were acquired using a 3T MRI scanner with a reduced field of view.
View Article and Find Full Text PDFEur J Dermatol
August 2024
Department of Dermatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Ann Surg Oncol
December 2024
Department of Surgical Oncology, Centre Hospitalier Lyon-sud, Lyon, Pierre Bénite, France.
Ann Pathol
September 2024
Service de pathologie multi-sites, centre hospitalier Lyon-Sud, hospices civils de Lyon, 69310 Pierre-Bénite, France; Centre pour l'innovation en cancérologie de Lyon (CICLY), UR3738, faculté de médecine et de maïeutique de Lyon-Sud-Charles-Mérieux, université Claude-Bernard-Lyon 1, 69921 Oullins, France. Electronic address:
Global warming and the disruption in ecosystems have been identified as the greatest threats to human health in the 21st century. Today, the French healthcare system accounts for 6.6% to 10% of overall greenhouse gas emissions in France.
View Article and Find Full Text PDFTransfus Apher Sci
October 2024
Terumo Blood and Cell Technologies, Ikaroslaan 41, Zaventem 1930, Belgium. Electronic address:
In France, sickle cell disease (SCD) is the most common rare disease and represents the most prevalent genetic disorder, with 19,800 to 32,400 patients diagnosed in 2016 and 1:714 newborns affected in 2019. SCD is caused by a single mutation in the β-globin gene, resulting in the production of abnormal hemoglobin (called HbS), chronic hemolytic anemia, and impaired red blood cell rheology. SCD patients face several severe acute and chronic complications, including stroke, acute chest syndrome (ACS), painful vaso-occlusive crisis (VOC), organ failure, and a high risk of infections.
View Article and Find Full Text PDFBlood
December 2024
Division of Hematology Oncology, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
J Med Syst
August 2024
PHE3ID, Centre International de Recherche en Infectiologie, Service d'Anesthésie Réanimation - Médecine Intensive, Institut National de la Santé et de la Recherche Médicale U1111, CNRS Unité Mixte de Recherche 5308, École Nationale Supérieure de Lyon, Université Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.
The integration of Computerized Provider Order Entry (CPOE) systems in hospitals has been instrumental in reducing medication errors and enhancing patient safety. This study examines the implications of a software oversight in a CPOE system : Metoclopramide had a concentrated formulation (100 mg) delisted (and then not manufactured) in 2014 due to safety concerns. Despite this, the CPOE system continued to accept prescriptions for this formulation because it was not removed from the medication library by the pharmacist.
View Article and Find Full Text PDFLancet Reg Health Eur
September 2024
French Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.
Int Forum Allergy Rhinol
December 2024
Department of Radiotherapy, Comprehensive Cancer Center François Baclesse, Caen, France. Université de Caen Normandie, ENSICAEN, CNRS/IN2P3, LPC Caen UMR6534, Caen, France.
Interpretation of surgical mapping is essential for postoperative radiotherapy planning. Operative and pathological reports lack comprehensive information on margins quality and tissue block mapping. Standardizing reports is essential to reduce uncertainties, aiming for less morbid poRT.
View Article and Find Full Text PDFWorld Allergy Organ J
July 2024
Dermatology Department, University Hospital of Montpellier, Montpellier, France.
In patients with moderate to severe atopic dermatitis (AD) showing an inadequate response to dupilumab 300mg/2weeks, few real-life studies reported the response to alternative regimen maintaining dupilumab. To assess and analyze the response to an increased dose of dupilumab or its combination with cyclosporin A (CsA), methotrexate (MTX), or itraconazole (ITRA), all adult AD patients from 7 French University Hospitals were retrospectively included if they achieved an inadequate response to dupilumab 300mg/2weeks and were subsequently treated with an increased dose of dupilumab (300mg every 7 or 10 days), or a combination of dupilumab 300mg/2weeks with CsA, MTX or ITRA. The response after 3 months, along with epidemiological, clinical, and therapeutic baseline characteristics, were collected.
View Article and Find Full Text PDFAnn Biol Clin (Paris)
August 2024
CHU Lille, Service de Biochimie Biologie Moléculaire, Univ. Lille, Laboratoire de Biochimie Biologie moléculaire, ULR 7364 - RADEME - Maladies RAres du DÉveloppement embryonnaire et du Métabolisme, F-59000 Lille, France.
The existence of alpha-1 antitrypsin variants with apparently unremarkable phenotypes and serum concentrations, contrasting with a clinical picture suggestive of a severe deficiency, led us to investigate whether in these cases there was a reduction or even suppression of the capacity of alpha-1 antitrypsin to inhibit elastase. To this end, in two different laboratories, we adapted and validated a method for measuring the functional activity of alpha-1 antitrypsin, based on spectrophotometric kinetic analysis of the inhibition by serum alpha-1 antitrypsin of the hydrolytic activity of porcine pancreatic elastase on a chromogenic substrate. This method has proved to be robust, reproducible and transferable and made possible to define, on the basis of an analysis of a hospital population, a functionality index with a confidence interval comprised between 0.
View Article and Find Full Text PDFJ Neurol
October 2024
French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 59 Bd Pinel, 69677, Bron cedex, France.
Background: Herpes simplex virus encephalitis (HSE) frequently triggers secondary anti-N-methyl-D-aspartate receptor encephalitis (NMDARE), but markers predicting the occurrence of this entity (HSE-NMDARE) are lacking.
Methods: We conducted a retrospective description of patients with HSE-NMDARE diagnosed between July 2014 and August 2022 and compared them to both patients with regular forms of HSE and NMDARE.
Results: Among the 375 patients with NMDARE, 13 HSE-NMDARE were included.
Clin Chem Lab Med
November 2024
French Clinical Oncopharmacology Group (GPCO)-UNICANCER, Paris, France.
Nat Commun
August 2024
Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.
Richter transformation (RT) is an aggressive lymphoma occurring in patients with chronic lymphocytic leukaemia. Here we investigated the anti-CD3/anti-CD19 T-cell-engager blinatumomab after R-CHOP (i.e.
View Article and Find Full Text PDFJ Visc Surg
December 2024
Hospices civils de Lyon, Department of Surgical Oncology, centre hospitalier Lyon Sud, 165, chemin du Grand Revoyet, 69310 Pierre-Bénite, France; EMR 3738, Claude-Bernard University, Lyon 1, Lyon, France. Electronic address:
Transpl Immunol
October 2024
Institut de Cancérologie des Hospices civils de Lyon (IC-HCL), Centre Hospitalier Lyon Sud, Service d'Oncologie Médicale, Oullins-Pierre-Benite, France; Faculté de médecine Jacques Lisfranc, Saint-Etienne, France.
Microvasc Res
November 2024
Université de Lyon, APCSe Agressions Pulmonaires et Circulatoires dans le Sepsis-, UP 2021.A101, VetAgro Sup, 1 Avenue Bourgelat, 69280 Marcy-l'Étoile, France. Electronic address:
Systemic inflammation and hemodynamic or microvascular alterations are a hallmark of sepsis and play a role in organs hypoperfusion and dysfunction. Pimobendan, an inodilator agent, could be an interesting option for inotropic support and microcirculation preservation during shock. The objectives of this study were to evaluate effect of pimobendan on cytokine and nitric oxide (NO) release and investigate whether changes of macro and microcirculation parameters are associated with the release of cytokines and NO in pigs sepsis model.
View Article and Find Full Text PDFCell Death Discov
August 2024
Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, 28 rue Laennec, 69008, Lyon, France.
Apoptosis plays a role in cell homeostasis in both normal development and disease. Bcl-xL, a member of the Bcl-2 family of proteins, regulates the intrinsic mitochondrial pathway of apoptosis. It is overexpressed in several cancers.
View Article and Find Full Text PDFInj Prev
August 2024
CRPPE de Lyon (Regional Center for Occupational and Environmental Pathologies), Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
Introduction: According to the 2018-2019 People Mobility Survey, work-related journeys (commuting and on-duty journeys) account for approximately 25% of all journeys. The use of non-motorised (nm) and motorised (m) personal mobility devices (PMDs) has steadily increased since their introduction into the French market in the last decade.
Objective: This study aimed to describe the characteristics of work-related road accidents and their evolution since the introduction of new PMDs in France and the increase in the use of scooters.
J Nucl Med
September 2024
King's College London and Guy's and St. Thomas's PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.
Total metabolic tumor volume (TMTV) is prognostic in lymphoma. However, cutoff values for risk stratification vary markedly, according to the tumor delineation method used. We aimed to create a standardized TMTV benchmark dataset allowing TMTV to be tested and applied as a reproducible biomarker.
View Article and Find Full Text PDFJ Feline Med Surg
July 2024
Université de Lyon, VetAgro Sup, Intensive Care Unit (SIAMU), Marcy l'Etoile, France.
Case Series Summary: This case series describes seven cats that were treated with high-flow nasal cannula oxygen therapy (HFNOT). Seven cats were prospectively (n = 5) or retrospectively (n = 2) included from three veterinary university referral centers between March 2020 and September 2023. Data on signalment, medical history, clinical and diagnostic findings, treatment administered, response to HFNOT and outcomes were recorded.
View Article and Find Full Text PDF